In this "Ask Me Anything" (AMA) episode, Peter answers a wide range of questions from subscribers. Bob Kaplan, Peter's head of research, asks the questions. If you're not a subscriber and listening on a podcast player, you'll only be able to hear a preview of the AMA.
If you're a subscriber, you can now listen to this full episode on your private RSS feed. You can also watch (or listen) to this full episode on our website at the AMA #8 show notes page.
Questions continue to be pulled from the AMA section on the website, and any subscriber is welcome to submit questions for future AMAs.
We discuss:
- Do DNA kits provide actionable info for cancer, CVD, diabetes, Alzheimer's, nutrition, or exercise? [1:45];
- What genes increase longevity? And do those genes show up on genetic tests like 23andMe? [12:00];
- Who are some people that Peter would like to have as guests on The Drive? [15:00];
- Inflammation: Is CRP a useful marker? What can one do to reduce it? And what other inflammatory markers can I look at to gauge health? [18:30];
- What lipid test does Peter now use on his patients? What are the three best cardiovascular laboratories? [28:00];
- Metformin for longevity: What considerations should one think about before doing taking metformin for longevity purposes? [32:30];
- What is Peter's take on salt and its role in things like high blood pressure and stomach cancer? [40:00];
- What markers does Peter find most interesting (and surprising) during his quarterly fasts? [47:30]; and
- More.
Learn more: https://peterattiamd.com/
Show notes page for this episode:http://peterattiamd.com/ama08
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/
Connect with Peter on Facebook | Twitter | Instagram.
Fler avsnitt av The Peter Attia Drive
Visa alla avsnitt av The Peter Attia DriveThe Peter Attia Drive med Peter Attia, MD finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
